Skip to main content
OMDA logo

OMDA · Omada Health, Inc. · Webcasts, Transcripts & Audio

Track OMDA — free
$20.57 +0.16 (+0.78%)
Market Cap
$1.20B
Shares
61.22M
Volume · Oct 1 1.44M Avg daily vol (3M) 1.4M

Omada Health, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Omada Health, Inc. (OMDA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Capital Markets Day
Investor event
2026-09-10
Omada Health, Inc. (OMDA) September 2026 Capital Markets Day Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-08-11
Omada Health, Inc. (OMDA) August 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-06
Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript
Confident tone PBM and HCSC Channel Expansion Operating Efficiency Cholesterol Product Launch
Revenue
$87.83M
▲ 43.1% YoY
Diluted EPS
$0.08
Gross margin
72.6%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-10
Omada Health, Inc. (OMDA) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Omada Health, Inc. (OMDA) Q1 2026 Earnings Call Transcript
Confident tone GLP-1 capabilities and channel expansion Enrollment and conversion Reach and employer relationships
Revenue
$78.05M
▲ 42% YoY
Diluted EPS
$-0.05
Gross margin
62.4%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-05
Omada Health, Inc. (OMDA) Q4 2025 Earnings Call Transcript
Confident tone Multi-Condition Platform Expansion Commercial Growth and Distribution Financial Results and Profitability
Revenue
$75.85M*
Gross margin
70.8%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Omada Health, Inc. (OMDA) Q3 2025 Earnings Call Transcript
Confident tone Revenue and membership growth GLP-1 strategy and prescribing Multi-product / multi-condition platform
Revenue
$68.03M
▲ 49.5% YoY
Diluted EPS
$-0.06
Gross margin
66.3%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Omada Health, Inc. (OMDA) Q2 2025 Earnings Call
Revenue
$61.37M
▲ 48.9% YoY
Diluted EPS
$-0.24
Gross margin
65.7%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–8 of 8 webcasts
Key facts CIK 1611115 CUSIP 68170A108 13F (30d) 3 filings 3 filers Visit website Investor relations